Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    inhaled treprostinil sodium | Open Studies
Show Display Options
Rank Status Study
1 Not yet recruiting Pulmonary Rehab in COPD: Response to Tyvaso
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: Inhaled Treprostinil
2 Recruiting Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1
Conditions: Pulmonary Hypertension;   COPD
Intervention: Drug: Inhaled Treprostinil Therapy
3 Not yet recruiting Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years
Condition: PAH
Intervention: Drug: oral treprostinil
4 Recruiting Beraprost-314d Added-on to Tyvaso® (BEAT)
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Beraprost Sodium 314d Modified Release Tablets;   Drug: Placebo
5 Not yet recruiting Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Condition: Persistent Pulmonary Hypertension of the Newborn
Interventions: Drug: IV Remodulin;   Drug: Placebo
6 Recruiting A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Ranolazine;   Drug: Placebo

Indicates status has not been verified in more than two years